BioNxt Solutions Inc.
BNXT
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -806.30K | -3.05M | -1.54M | -1.16M | -939.80K |
| Total Depreciation and Amortization | 500.00 | 800.00 | 3.20K | 4.00K | 4.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 410.20K | 2.44M | 682.10K | 276.70K | 245.60K |
| Change in Net Operating Assets | -198.10K | 185.90K | 68.70K | -587.70K | 141.40K |
| Cash from Operations | -593.80K | -423.00K | -786.00K | -1.47M | -547.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 13.60K | 50.70K | 2.70K | 35.30K | 1.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -36.30K | -- |
| Cash from Investing | 13.60K | 50.70K | 2.70K | -1.00K | 1.30K |
| Total Debt Issued | -- | -- | 0.00 | 1.25M | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 2.13M | 474.80K | 677.90K | 1.36M | 431.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.00K | -- | 0.00 | -115.00K | 0.00 |
| Cash from Financing | 1.42M | 341.40K | 486.30K | 1.81M | 311.90K |
| Foreign Exchange rate Adjustments | 300.00 | -100.00 | 300.00 | 300.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 838.10K | -31.10K | -296.60K | 337.30K | -234.80K |